Max Robotics — Global Service Robot Directory + US Certification

About

Daniel G. Bracewell is a prominent bioprocess engineer whose research sits at the intersection of biopharmaceutical manufacturing, chromatographic purification, and emerging cell-free protein synthesis technologies. His work has made significant contributions to accelerating and streamlining the development of therapeutic proteins, vaccines, and antibody-based products. Bracewell is perhaps best known for pioneering microscale and automated approaches to bioprocess development. His 2007 paper on automated microscale chromatographic purification of virus-like particles (66 citations) demonstrated how miniaturized systems could dramatically accelerate recombinant vaccine development by enabling rapid screening of purification strategies without consuming large quantities of material. Complementing this, his microscale chromatography predictive modeling work (2009, 33 citations) and automated micro-pipette tip assay for polyclonal antibody quantification (2010, 21 citations) further established microscale methodologies as reliable, high-throughput tools for therapeutic protein recovery. More recently, Bracewell has expanded into cell-free protein synthesis, applying design of experiments strategies to optimize Pichia pastoris-based systems (2020, 33 citations), reflecting his commitment to advancing next-generation biomanufacturing platforms. Collectively, his research has helped reduce the time, cost, and resource demands associated with biopharmaceutical process development, making his contributions highly valuable to both academic researchers and industrial practitioners in the field.